COVID-19 trials registries data warehouse

http://www.chictr.org.cn/showproj.aspx?proj=50727

Guojun Zhang

zlgj-001@126.com

2020-03-08

Recruiting

RCT

Randomized

Parallel

Not reported

single-center

Treatment

Patients who were diagnosed as COVID-19 by nucleic acid test and were in accordance with the clinical classification of severe or critically illness. (refer to the clinical classification criteria in the pneumonia diagnosis and treatment program of novel coronavirus infection, General Office of the National Health Commission (trial version 4)).

Patients with hypersensitivity to plasma products, patients with severe transfusion reactions in the past, patients with acute pulmonary edema, congestive heart failure, pulmonary embolism, malignant hypertension, polycythemia vera, extreme renal failure and other diseases.

2

The First Affiliated Hospital of Zhengzhou University

None

None

China

Severe/critical disease at enrollment

7: Severe/critical disease at enrollment

30

Tempreture;Virus nucleic acid detection;

| Declared number of arm (2.0) differs from found arms (3.0)

Phase 0

[{"arm_notes": "", "treatment_id": 322, "treatment_name": "Convalescent plasma", "treatment_type": "Convalescent plasma", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]